Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy

INTRODUCTION AND OBJECTIVE: Patient perception of overactive bladder (OAB) treatment outcomes can be a useful indicator of benefit and may help drive persistence on treatment, which is known to be poor in OAB. It remains unclear whether OAB patients dissatisfied with one antimuscarinic can achieve s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zinner, N, Kobashi, K C, Ebinger, U, Viegas, A, Egermark, M, Quebe-Fehling, E, Koochaki, P
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Overactive Bladder
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680263/
https://www.ncbi.nlm.nih.gov/pubmed/18811599
http://dx.doi.org/10.1111/j.1742-1241.2008.01893.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680263/
https://www.ncbi.nlm.nih.gov/pubmed/18811599
http://dx.doi.org/10.1111/j.1742-1241.2008.01893.x

Ejemplares similares